LUYE PHARMA 02186
1.7301.98%( -0.035 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
LUYE PHARMA (02186) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| LIU Dian BoExecutive Director | 31.20% | 1.25B | |
| UBS Group AG | 14.04% | 560.96M | |
| Hillhouse Investment Management, Ltd. | 13.83% | 552.32M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| LuYe Pharmaceutical Investment Co., Ltd. | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| LuYe Pharmaceutical Investment Co., Ltd. | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| LuYe Pharmaceutical International Co., Ltd. | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| LuYe Pharmaceutical International Co., Ltd. | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| Luye Pharma Holdings Ltd. | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| Luye Pharma Holdings Ltd. | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| Luye Life Sciences Group Ltd | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| Luye Life Sciences Group Ltd | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| Nelumbo Investments Limited | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| Nelumbo Investments Limited | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| Ginkgo (PTC) Limited | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| Ginkgo (PTC) Limited | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| Shorea LBG | 8.54M | -- | Lent shares returned | 1.25B | 31.20% | ||
| Shorea LBG | 8.54M | -- | Other event (short) | 203.69M | 5.10% | ||
| UBS Group AG | 33.25M | -- | Other event (short) | 492.74M | 12.34% | ||
| UBS Group AG | 33.25M | -- | Other event | 560.96M | 14.04% | ||
| UBS Group AG | 17.38M | -- | Other event | 527.71M | 13.21% | ||
| UBS Group AG | 17.80M | -- | Other event | 512.71M | 12.84% | ||
| UBS Group AG | 17.80M | -- | Other event | 528.74M | 13.24% | ||
| UBS Group AG | -2.63M | 2.15 | Sold | 518.62M | 12.98% | ||
| UBS Group AG | +2.07M | 2.14 | Bought | 519.32M | 13.00% | ||
| UBS Group AG | 33.98M | -- | Other event (short) | 460.80M | 11.54% | ||
| UBS Group AG | 33.98M | -- | Other event | 517.85M | 12.96% | ||
| UBS Group AG | 33.98M | -- | Other event (short) | 495.08M | 12.39% | ||
| UBS Group AG | 33.98M | -- | Other event | 552.11M | 13.82% | ||
| UBS Group AG | 29.00M | -- | Shares borrowed (short) | 461.05M | 11.54% | ||
| UBS Group AG | 23.86M | -- | Other event (short) | 432.09M | 10.82% | ||
| UBS Group AG | 23.86M | -- | Other event | 507.21M | 12.70% | ||
| UBS Group AG | 23.86M | -- | Other event | 538.30M | 13.48% | ||
| UBS Group AG | 23.86M | -- | Other event | 504.35M | 12.63% | ||
| UBS Group AG | 18.03M | -- | Other event | 532.45M | 13.33% | ||
| UBS Group AG | 8.67M | -- | Derivatives expired or cancelled | 515.21M | 12.90% | ||
| UBS Group AG | 8.67M | -- | Borrowed shares returned (short) | 477.13M | 11.94% | ||
| UBS Group AG | 18.03M | -- | Other event | 550.99M | 13.79% | ||
| UBS Group AG | 33.98M | -- | Other event | 562.02M | 14.07% | ||
| UBS Group AG | 134.46M | -- | Shares borrowed (short) | 481.67M | 12.06% | ||
| UBS Group AG | 13.99M | -- | Other event | 532.97M | 13.34% | ||
| UBS Group AG | 8.67M | -- | Other event | 517.14M | 12.95% | ||
| UBS Group AG | 8.84M | -- | Borrowed shares returned (short) | 352.81M | 8.83% | ||
| UBS Group AG | 35.34M | -- | Other event | 522.31M | 13.08% | ||
| UBS Group AG | 54.94M | -- | Other event | 506.47M | 12.68% | ||
| UBS Group AG | 1.62M | -- | Other event (short) | 399.40M | 9.99% | ||
| UBS Group AG | 164.10M | -- | Other event | 571.59M | 14.31% | ||
| UBS Group AG | -106.80M | 1.92 | Sold | 421.87M | 10.56% |
This page shows the major shareholders of LUYE PHARMA (02186) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
